A Real Life Experience with the Comsos Regimen in Genotype 1 Chronic Hepatitis C Treatment: Including Patients with East Asian Ancestry and Decompensated Cirrhosis

BACKGROUND/AIMS: The COMSOS phase 2 trial showed high cure rates and a favorable side effect profile of a 12-week regimen of Sofosbuvir (SOF) and Simeprevir (SIM) in patients with a genotype 1 Hepatitis C infection. However, given the small number of patients in the COSMOS trial, there is uncertaint...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hawaii J Med Public Health
Hlavní autoři: Roytman, Marina, Ramkissoon, Resham, Hong, Leena, Trujillo, Ruby, Huddleston, Leslie, Poerzgen, Peter, Seto, Todd, Tsai, Naoky
Médium: Artigo
Jazyk:Inglês
Vydáno: University Clinical, Education & Research Associate (UCERA) 2015
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582373/
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky